News
Mass Gen's Dr. Ali Raja explains why some were sent to the emergency room after using semaglutide injections. Raja says some of the symptoms people experienced won't require an ER visit. Raja says not ...
A major international study has found that semaglutide, a drug already used to treat type 2 diabetes and obesity, can ...
Though popular weight loss jabs like Ozempic and Wegovy have been deemed safe and effective by the FDA, concerning side ...
You may have heard of "Ozempic face" and "Ozempic butt." Well, now there's "Ozempic mouth" and "Ozempic feet" to describe ...
With pharmaceutical GLP-1 drugs like semaglutide in high demand, Metamorphx offers a plant-based alternative designed to ...
Novo Nordisk has pulled ahead in the race to bring the first oral GLP-1 for obesity to market. The company announced Friday ...
People with celiac disease had no problems after kissing a partner who'd just eaten a stack of saltine crackers, according to ...
22h
Pharmaceutical Technology on MSNFDA accepts Novo Nordisk’s NDA submission for weight management therapyThe US FDA has accepted Novo Nordisk’s new drug application (NDA) submission for the 25 mg oral formulation of Wegovy ...
Deals with Hims & Hers, LifeMD and Ro follow dismissal of a lawsuit that challenged the FDA's determination Wegovy is no ...
5d
GlobalData on MSNMagazine: The GLP-1 shortage is over. What’s next for compounders?The future for GLP-1RA compounders, steps pharma can take in light of rising trial costs, funding ultra-rare therapies, and ...
Novo Nordisk appears to be letting compounded GLP-1 bygones be bygones—at least, in one respect. | Novo Nordisk appears to be ...
AquaSculpt is a stimulant-free fat loss supplement getting attention in 2025 for its unique approach: triggering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results